Smokeless tobacco (SLT) use, a form of tobacco consumed without combustion/burning, has become a global health issue with about 350 million users, maximally seen in the South-East Asian Region. Its use is associated with a myriad of adverse effects, with the major ones being oral cancer, myocardial infarction and other cardiovascular diseases[@ref1].

Article 14 of the World Health Organization Framework Convention on Tobacco Control (WHO-FCTC) deals with tobacco addiction and dependence treatment measures. It states that 'each Party shall develop and disseminate appropriate, comprehensive and integrated guidelines based on scientific evidence and best practices, taking into account national circumstances and priorities, and shall take effective measures to promote cessation of tobacco use and adequate treatment for tobacco dependence[@ref2].' The formulation of this Article demonstrates the fact that the FCTC realizes the addictive potential of tobacco. Hence, the same came into existence at the Conference of the Parties 4 with the objective of development of effective treatment guidelines and measures to promote adequate treatment for tobacco dependence, by the member Parties[@ref3]. However, the average implementation of Article 14, as reported in the Global Progress Report on Implementation of the WHO-FCTC in 2016[@ref4], has not been significant, *i.e*. 50 per cent, between 2012 and 2016, as compared to the other substantive articles of the Convention[@ref5]. According to the guidelines of Article 14, tobacco cessation has multiple dimensions to it, comprising behavioural interventions \[brief advice, telephone counselling *via* national toll-free quitlines (NQLs)\], pharmacotherapy, nicotine replacement therapy (NRT) and non-nicotine therapy - bupropion and varenicline, involvement of the healthcare system/healthcare workers, noting individual\'s tobacco use[@ref2].

In spite of widespread use and adverse health consequences of SLT, there is a dearth of evidence-based published literature on SLT cessation as compared to that on smoking cessation. A systematic review and meta-analysis available for SLT cessation intervention trials was the Cochrane review reporting data till 2015, majorly for studies performed in the United States of America (USA), with a few in the Scandinavian countries[@ref6]. Here we provide a global update on the existing literature regarding studies on the demand reduction measures concerning SLT dependence and cessation, along with evidence-based discussion of the efficacy of each.

Material & Methods {#sec1-2}
==================

To search the literature and systematically review the various demand reduction measures for SLT dependence and cessation, an online search strategy was performed since inception (1966) for PubMed to 2017, and the resultant data evaluated, as shown in [Figure](#F1){ref-type="fig"}.

![Flow chart showing search strategy. ^\*^These were the number of articles which were chosen for screening of their abstracts after excluding other articles deemed irrelevant based on their titles.](IJMR-148-396-g001){#F1}

Extensive PubMed and Google literature search was performed using a combination of keywords such as smokeless tobacco, cessation, interventions, dependence, treatment, quitlines, behavioural, brief advice, nicotine replacement therapy, nicotine gum, nicotine lozenge, nicotine patch, bupropion, varenicline, dentist, mHealth and mobile. This search produced 28,756 results, the titles of which were assessed and those not relevant were excluded. Abstracts of the remaining publications and full papers were reviewed to identify those that fulfilled the inclusion criteria. Among these, 59 articles were found to be of potential interest and were included.

The criteria for data selection, obtained from the search above, were as follows:

 {#sec2-1}

### Inclusion criteria {#sec3-1}

Studies performed for SLT cessation interventions; studies performed for cessation of both smoking and SLT but also reporting data specific to SLT cessation; those with the most recent results for consecutively reported studies; SLT cessation intervention studies performed either on adults or adolescents were included. Only English language literature was included.

### Exclusion criteria {#sec3-2}

Studies only for smoking cessation; studies for cessation of both smoking and SLT but not providing separate information for SLT cessation; literature reviews; repetitive data (example: extracts from already included Cochrane articles); articles on tobacco use screening and counselling; study protocols; studies with differing objectives; old published data for the same study; unavailability of the complete report for reference in case of lack of clarity of information in the abstract; documents in languages other than English, were excluded.

The current status of availability of the SLT dependence and cessation measures globally and the efficacy of each of the SLT cessation intervention was assessed based on the risk ratio (RR) \[confidence intervals (CIs)\] and quit rates reported for each of them in the various resultant studies.

Results {#sec1-3}
=======

 {#sec2-2}

### Behavioural interventions for smokeless tobacco (SLT) cessation {#sec3-3}

Twenty randomized controlled trials (RCTs) (case-control studies) on behavioural interventions for SLT cessation were reported; sixteen were conducted in the USA[@ref7][@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22], three in India[@ref23][@ref24][@ref25] while only one study was reported from Sweden[@ref26]. Most studies had majority of adult participants while three were conducted among the youth[@ref13][@ref20][@ref24]. Among the 19 studies having a follow up of six months or more, 10 studies reported statistically and clinically significant benefits with RR (CI) ranging between 1.33 (1.09, 1.63) and 3.84 (2.33, 6.33)[@ref9][@ref10][@ref11][@ref13][@ref14][@ref17][@ref18][@ref19][@ref22][@ref23], in five studies the CIs did not specify a clinical benefit but did not exclude one either, with an RR (CI) between 1.08 (0.84, 1.39) and 3.72 (0.79, 7.47)[@ref7][@ref12][@ref16][@ref20][@ref26] and four studies had RRs just below or above one and relatively narrow CI suggesting no important benefit or harm *i.e*. RR (CI) from 0.87 (0.7, 1.09) upto 1.07 (0.87, 1.31)[@ref8][@ref15][@ref21][@ref24]. Overall, the RR (CI) ranged from 0.87 (0.7, 1.09) to 3.84 (2.33, 6.33). The one case-control pilot study conducted by Jhanjee *et al*[@ref25] showed an RR (CI) of 1.80 (0.77, 4.25) at the end of three months of treatment ([Table I](#T1){ref-type="table"}). Therefore, the trials suggested a benefit of behavioural interventions in SLT cessation.

###### 

Details of the smokeless tobacco (SLT) cessation intervention randomized controlled trials (RCT) and cohort studies

  Authors                                                              Year   Country                         Study type         Subject characteristics             Intervention period/method   Follow up period   Risk ratio and CI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  -------------------------------------------------------------------- ------ ------------------------------- ------------------ ----------------------------------- ---------------------------- ------------------ ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------ -------------------------------------------------------------------
  NRT with behavioural interventions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Boyle *et al*[@ref40]                                                1992   USA                             RCT                100                                 50                           50                 Average age 32                                                                       6 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1, 6 and 12 months             1.00 (0.52-1.94)
  Hatsukami *et al*[@ref41]                                            1996   USA                             RCT                210 males                           106                          104                Average age 31                                                                       Pharmacotherapy - 8 wk,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    12 months                      0.98 (0.63-1.54)
  Behaviour therapy - 10 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Howard-Pitney *et al*[@ref42]                                        1999   USA                             RCT                410 males                           206                          204                Average age 36                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  6 months                       1.12 (0.86-1.45)
  Hatsukami *et al*[@ref43]                                            2000   USA                             RCT                402                                 201                          201                Average age 31                                                                       10 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Up to 62 wk                    1.27 (0.92-1.74)
  Stotts *et al*[@ref44]                                               2003   USA                             RCT                303 males                           198                          105                14-19                                                                                6 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       12 months                      1.26 (0.57-2.78)
  Croucher *et al*[@ref54]                                             2003   UK                              Pilot study        130 UK-resident Bangladeshi women   65                           65                 Average age 42.5                                                                     4 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1.25 (0.58-2.68)
  Ebbert *et al*[@ref45]                                               2007   USA                             RCT                42 males                            10                           11                 Average age 34-38 (20-56)                                                            8 wks                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      6 months                       1.10 (0.19-6.41)
  Ebbert *et al*[@ref46]                                               2009   USA                             RCT                270 (264 males and 6 females)       136                          134                18 and above (average age 37)                                                        12 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      6 months                       1.40 (0.88-2.22)
  Ebbert *et al*[@ref47]                                               2010   USA                             RCT                60 males                            30                           30                 18 yr and above (average age: randomized group 43.6±16.0, control group 42.4±11.7)   12 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      6 months                       0.73 (0.34-1.55)
  Croucher *et al*[@ref53]                                             2012   UK                              Cohort             239 South Asians                    219                          20                 Average age 45                                                                       4 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1 yr                           1.62 (0.94-2.80)
  Croucher *et al*b[@ref52]                                            2012   UK                              Cohort             419 UK resident Bangladeshi women   330                          89                 Average age 48.9                                                                     4 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      4.93 (2.02-12.00)
  Ebbert *et al*[@ref49]                                               2013   USA                             RCT                52                                  25                           27                 Average age 41 (18-55)                                                               8 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       6 months                       1.73 (0.65-4.59)
  Ebbert *et al*[@ref48]                                               2013   USA                             Pilot study        130 (125 males and 5 females)       40                           41                 18 yr and above (average age 38)                                                     12 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      6 months                       1.03 (0.32-3.27)
  Danaher *et al*[@ref50]                                              2015   USA                             RCT                407 (397 males and 10 females)      205                          202                Average age 35                                                                       12 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      3 and 6 months                 1.53 (1.12-2.09)
  Severson *et al*[@ref51]                                             2015   USA                             RCT                1067 males                          357                          354                Average age 36                                                                       12 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      3 and 6 months                 1.36 (1.12-1.66), 1.43 (1.20-1.71)
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Behavioural interventions only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Gupta *et al*[@ref23]                                                1992   India                           Cohort study       7033 males and females SLT users    4619                         2414               15 yr and above                                                                      Intervention group: Concentrated programme of education against tobacco use. Control group: minimal advice against tobacco use                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             10 yr                          2.79 (2.36, 3.29)
  Cummings *et al*[@ref8]                                              1995   USA                             RCT                733 males                           316                          417                Average age 36                                                                       2 yr                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       2 yr                           0.98 (0.76-1.27)
  Stevens *et al*[@ref7]                                               1995   USA                             RCT                518 males                           245                          273                15 yr and above                                                                      18 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  3 and 12 months                1.47 (0.83-2.60)
  Severson *et al*[@ref9]                                              1998   USA                             RCT                633                                 394                          239                15 yr and above                                                                      3 and 12 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            3 and 12 months                3.03 (1.44-6.37)
  Walsh *et al*[@ref10]                                                1999   USA                             RCT                360                                 171                          189                                                                                                     Intervention group: Oral exam (3-5 min) with feedback, photos of ST effects, advice to quit, self-help manual, optional brief counselling (15-20 min) about quit date, triggers, tobacco withdrawal); optional nicotine gum (to mitigate withdrawal symptoms), optional phone counselling. Controls: Oral examination only                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Up to 1 yr                     2.21 (1.5-3.25)
  Andrews *et al*[@ref11]                                              1999   USA                             RCT                633 (632 males and 1 female)        394                          239                15 yr and above (Average age 36.2)                                                   Intervention: Determine tobacco use, identify oral disease, strong advice to quit, set quit date within two wk, motivation video, written material, call patient within two wk; Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 3 and 12 months                3.26 (1.49-7.17)
  Cigrang *et al*[@ref12]                                              2002   USA                             Pilot study        60 males                            31                           29                 Average age 31 (19-47)                                                               Programme using motivational interviewing consisted of a treatment manual, video, and two supportive phone calls (about 10 min each) from a cessation counsellor                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           3 and 6 months                 2.18 (0.62-7.65)
  Walsh *et al*[@ref13]                                                2003   USA                             RCT                307 males                           141                          166                14-18                                                                                Peer-led component (50-60 min): Interactive, peer-led team directing education with videotape and brief discussion (10-15 min), slide show (20-30 min), and small-group discussion on tobacco industry advertising (10 min). Dental component with oral cancer screening examination by a dentist or hygienist. Included advice to quit, a self-help guide, tobacco cessation counselling in small groups (15 min), and a phone call on the quit date (5-10 min). Control group: No intervention                                                                                                                                                                                                                                                                                           1 and 12 months                1.95 (1.22-3.10)
  Boyle *et al*[@ref14]                                                2004   USA                             RCT                221 males                           109                          112                Average age 36                                                                       Behavioural therapy 1. S-H materials (control) 2. S-H material + 4 proactive telephone counselling calls. Initial call four days after S-H material mailing. Subsequent calls were negotiated and placed emphasis on support, problem-solving, and use of cognitive-behavioural strategies including monitoring tobacco behaviour patterns, goal setting, finding alternative coping options and planning for high-risk situations or cues associated with tobacco use                                                                                                                                                                                                                                                                                                                     6 months                       1.61 (1.09-2.39)
  Gansky *et al*[@ref15]                                               2005   USA                             RCT                637                                 285                          352                17-20                                                                                Intervention: 1. Three-hour video conference training for athletic trainers/dentists/hygienists; follow up newsletter for athletic trainers 2. Oral cancer screening by dentists/hygienists 3. Athletic trainer follow up and referral with follow up by trainer on quit date, plus 3 booster sessions one week apart 4. Peer-led component with education meeting (50-60 min). Control: anti-tobacco education                                                                                                                                                                                                                                                                                                                                                                            1 yr                           0.98 (0.80-1.20)
  Severson *et al*[@ref16]                                             2007   USA                             RCT                1069 males                          535                          534                Average age 39 (17-82)                                                               Assisted self-help including: 1. Phone support (two calls, 10-15 min, with quit date setting and tobacco withdrawal management) 2. Self-help manual (60 pages) 3. Self-help videos (20 min). Controls received a self-help manual                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          12 months                      1.32 (0.94-1.86)
  Stigler *et al*[@ref24]                                              2007   India                           Cohort study       209 girls and boys                  100                          109                10-16                                                                                Four months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                2 yr (here, outcome of 1 yr)   0.87 (0.7-1.09)
  Severson *et al*[@ref18]                                             2008   USA                             RCT                2523 males                          1260                         1263               Average age 36.8                                                                     Intervention (enhanced website): a guided interactive programme for quitting tobacco, useful resources and other weblinks, web forums namely 'Talk with Others' and 'Ask an Expert', planning to quit and staying quit modules Controls (basic website): a static website having a pocket guide titled "Enough Snuff "and a section with useful materials and links                                                                                                                                                                                                                                                                                                                                                                                                                        3 & 6 months                   1.59 \[1.26, 2.02\]
  Boyle *et al* (the Chew Free Minnesota study)[@ref17]                2008   USA                             RCT                406 (399 males and 7 females)       201                          205                Average age 40                                                                       A self-help manual plus proactive phone-based cessation counselling. Phone-based treatment included up to 4 calls in support of quitting and personalized cognitive and behavioural tobacco treatment strategies (*e.g.,* setting a quit date, examining use patterns, developing stress-reduction skills, avoiding known triggers to use). Controls received usual care (*i.e.,* self-help manual only)                                                                                                                                                                                                                                                                                                                                                                                   3 and 6 months                 3.16 (1.99-5.03)
  Severson *et al*[@ref19]                                             2009   USA                             RCT                785 males                           392                          393                Average age 30                                                                       Telephone counselling by a trained cessation counsellor who offered assistance in quitting ST use (3 calls: First call one week after dental examination, second call three weeks after quitting materials were mailed, third call a few days after participant's quit date or two weeks after the second call); a mailed videotape and self-help guide tailored for the military. Controls received usual care                                                                                                                                                                                                                                                                                                                                                                            6 months                       3.84 (2.33-6.33)
  Walsh *et al*[@ref20]                                                2010   USA                             RCT                4731 males                          123                          123                14-18                                                                                Peer-led educational session (45 min), oral exam with feedback, and three nurse-led group cessation counselling sessions (one hour each, optional). Peer-led sessions included video/slide presentation and discussion about the presentations and how the tobacco industry targets young males. Oral examination included feedback about any tobacco-related lesions, advice to quit using ST, assessing of readiness to quit. The first nurse-led session focused on assessment, education, preparation to get ready to quit, and the importance of social support; the second session focused on setting a quit date and skills to cope with cravings and temptation to use; the third session reviewed progress and focused on relapse prevention. Controls received no intervention   1 yr                           1.08 (0.84-1.39)
  Danaher *et al*[@ref21]                                              2013   USA                             RCT                1716 (1656 males and 60 females)    857                          859                Average age 21 (14-25)                                                               Behavioural therapy 1. Basic condition (control): Static website content including an 'Enough Snuff' pocket guide, a resource section with informational materials and links to websites offering content for ST cessation and relaxation strategies 2. Enhanced condition: Interactive and multimedia features with functionality to create online lists, watch videos, and a Web blog moderated by research staff. Automated email reminders encouraged website use and provided supportive measures                                                                                                                                                                                                                                                                                     3 and 6 months                 1.07 (0.87-1.31)
  Danaher *et al*[@ref22]                                              2015   USA                             RCT                1683 (1641 males and 42 females)    1259                         424                Average age 38                                                                       Behavioural therapy: 1. Web only: Automated, tailored and interactive intervention delivered as text, activities, and videos 2. Quitline only: Proactive telephone counselling through the California Tobacco Chewers' Helpline 3. Web + Quitline: Received the Web and Quitline Interventions 4. Control: Self-help printed guide                                                                                                                                                                                                                                                                                                                                                                                                                                                         3 and 6 months                 1.33 (1.09-1.63)
  Virtanen *et al* (the FRITT study)[@ref26]                           2015   Scandinavia (Sweden)            RCT                241 males and females               94                           100                18-75                                                                                Behavioural therapy: 1. Structured tobacco use intervention based upon the 5 A's specifically referring to oral health with reference to pharmacotherapy, more intensive counselling in the primary care clinic and the telephone quitline. Hand-outs supplied 2. Usual care                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               6 months                       3.72 (0.79-17.47)
  Jhanjee *et al*[@ref25]                                              2017   India                           Pilot study        100 women                           50                           50                 Average age 43                                                                       3 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  1.80 \[0.77, 4.25\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Non-nicotine therapy (with behavioural interventions): Bupropion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Glover *et al*[@ref59]                                               2002   USA                             Double-blind RCT   70 males                            35                           35                 18 & above                                                                           7 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       5 wk                           2.73 \[1.07, 7.72\] (at 7 wk), 1.93 \[0.71, 5.47\] (at follow up)
  Dale *et al*[@ref60]                                                 2002   USA                             RCT                68 (67 males, 1 female)             34                           34                 Average age 37                                                                       12 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      24 wk                          1 \[0.27, 3.68\]
  Dale *et al*[@ref61]                                                 2007   USA                             RCT                225 males                           113                          112                Average age 38 (19-72)                                                               12 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      24 & 52 wk                     0.87 \[0.51, 1.46\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Non-nicotine therapy (with behavioural interventions): Varenicline                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Fagerstrom *et al*[@ref62]                                           2010   Scandinavia (Sweden & Norway)   RCT                431 (385 males & 46 females)        213                          218                Average age 43.9                                                                     12 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      6 months                       1.33 \[1.05, 1.69\]
  Ebbert *et al*[@ref63]                                               2011   USA                             RCT                76 males                            38                           38                 Average age 41                                                                       12 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      3 & 6 months                   1.42 \[0.79, 2.55\]
  Jain *et al*[@ref64]                                                 2014   India                           Double-blind RCT   237 (mostly males)                  119                          118                Average age 34.2                                                                     12 wk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     2.60 \[1.20, 4.20\]

SLT, smokeless tobacco; RCT, randomized controlled trials

Twelve non-case-control studies employing behavioural interventions for SLT cessation interventions were found, among which eight had a follow up of six months or more[@ref27][@ref28][@ref29][@ref30][@ref31][@ref32][@ref33][@ref34] and four had a follow up of less than six months[@ref35][@ref36][@ref37][@ref38]. Of these, two studies were performed in India[@ref30][@ref32], one in Pakistan and United Kingdom (UK)[@ref33] and the rest were done in the USA[@ref27][@ref28][@ref29][@ref31][@ref34][@ref38]. Among the group having intervention/follow up of less than six months, the quit rate ranged from eight per cent (at the end of one month, Gala *et al*) to 58 per cent (after 1.5 months, Fisher *et al*)[@ref37][@ref38]. The quit rate of SLT users in the trials having a longer follow up of six months or more was between 9 per cent (at six months, Walsh *et al*) and 51.5 per cent (after 12 months, Mishra *et al*)[@ref27][@ref30] ([Table II](#T2){ref-type="table"}).

###### 

Details of smokeless tobacco cessation intervention non case-control studies

  Authors                                                            Country        Year   Study type                                             Subject characteristics                                        Intervention period              Follow up period   Quit rate (%)                                    
  ------------------------------------------------------------------ -------------- ------ ------------------------------------------------------ -------------------------------------------------------------- -------------------------------- ------------------ ------------------------------------------------ ---------------------------------------------
  Behavioural interventions only                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                      
  Eakin *et al*[@ref35]                                              USA            1989   Pilot study                                            25 males                                                                                                           3 months                                         16
  Masouredis *et al*[@ref36]                                         USA            1997   RCT                                                    1208 males                                                                                                         3 months                                         24
  Walsh *et al*[@ref27]                                              USA            1998   Pilot study                                            304 males                                                      Minor and major league players                      6 months                                         9
  Boyle *et al*[@ref28]                                              USA            1999   Media campaign                                         205 males                                                      21-79 Average age=37.5                              1 yr                                             11.5
  Fisher *et al*[@ref37]                                             USA            2001   Cohort study                                           50 (49 males, 1 female)                                        18 and above                                        6 wk                                             58
  Lichtenstein *et al*[@ref29]                                       USA            2002                                                          363 female romantic partners of male smokeless tobacco users   Average age=40                                      6 months                                         32
  Gala *et al*[@ref38]                                               USA            2008   Cohort study                                           18 males                                                       18 and above                                        1 month                                          8
  Mishra *et al*[@ref30]                                             India          2009   Cohort study                                           104 males                                                                                       1 yr               51.5                                             
  Meier *et al*[@ref31]                                              USA            2013   Institutional intervention                             2293 males                                                     18-56 (average age =20.6)                           4 yr                                             16.4
  Mishra *et al*[@ref32]                                             India          2014   Community-based intervention                           304 women                                                                                       1 yr                                                                33.5
  Siddiqi *et al*[@ref33]                                            UK, Pakistan   2016   Pilot study                                            32 (16 males and 16 females)                                   18 and above                                        6 months                                         12.5
  Gupta *et al*[@ref34]                                              India          2016   Quitline                                               1105                                                           Majority between 16-25           1 call session     1 wk, 1 month, 3 months, 6 months, 1 yr          20.0 (at 18 months)
                                                                                                                                                                                                                                                                                                                      
  NRT with behavioural interventions                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                      
  Sinusas *et al*[@ref56]                                            USA            1993   Preliminary trial                                      14 males                                                       2-4 months                       Up to 12 months    21 (at the end of treatment), 7 (at follow up)   
  Hatsukami *et al*[@ref57]                                          USA            2003   Pilot study                                            40 males                                                       Average age=31.9                 12 wk              At 26 wk                                         25 (at end of treatment) 15 (at follow up)
  Ebbert *et al*[@ref58]                                             USA            2007   Open-label, one-arm, phase II clinical trial           30 (29 males, 1 female)                                        Average age=35.4                 12 wk              6 months                                         53 (at end of treatment), 47 (at follow up)
  Wallstrom *et al*[@ref55]                                          Sweden         2010   Prospective, open, non-randomized intervention trial   50 males                                                       Average age=42.2                 Six wk             3, 6, 12 months                                  30 (at 12 months)
  Mushtaq *et al*[@ref39]                                            USA            2015   Cohort study                                           374 males                                                      Average age=41.3                 7 months           43                                               
                                                                                                                                                                                                                                                                                                                      
  Non-Nicotine therapy with behavioural interventions: Varenicline                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                      
  Ebbert *et al*[@ref47]                                             USA            2010   Pilot study                                            20 males                                                       Average age=42.8                 12 wk              6 months                                         15 (at 12 wk) 10 (at 6 months)

NRT, Nicotine replacement therapy

[National toll-free quitlines (NQLs)]{.ul}: Telephone support has been shown to be efficacious in SLT cessation. Among the aforementioned studies, 10 RCTs conducted in the USA, in which telephone support formed part of the intervention showed their benefit, with RR (CI) ranging between 1.32 (0.94, 1.86) and 3.84 (2.33, 6.33) ([Table I](#T1){ref-type="table"})[@ref7][@ref9][@ref10][@ref12][@ref13][@ref14][@ref16][@ref17][@ref19][@ref22]. Four non case-control studies[@ref28][@ref34][@ref35][@ref39] reported a beneficial effect of telephone support for SLT cessation. A quit rate of 20 per cent among SLT users at the end of 18 months of the quitline activity in Rajasthan (India), a voluntary activity of Rajasthan Cancer Foundation, was reported[@ref34]. A media campaign (comprising of quitline component) in Nebraska (USA)[@ref28] reported a quit rate of 11.5 per cent at the end of 12 months and Eakin *et al* (USA)[@ref35] reported a quit rate of 16 per cent at the end of three months in their multi-component behavioural intervention programmes including frequent telephone contact/counselling with the SLT users. Mushtaq *et al*[@ref39] reported a quit rate of 43 per cent at the end of seven months; however, the intervention also involved delivery of NRT in addition ([Table II](#T2){ref-type="table"}).

### Pharmacotherapy for SLT cessation {#sec3-4}

[Nicotine replacement therapy (NRT)]{.ul}: Fifteen RCTs on NRT for SLT cessation were found. Twelve trials were performed in the USA[@ref40][@ref41][@ref42][@ref43][@ref44][@ref45][@ref46][@ref47][@ref48][@ref49][@ref50][@ref51] while three were conducted in the UK among Bangladeshi-resident women[@ref52][@ref53][@ref54]. Except one[@ref44], the rest of the studies had adult participants. Among the 12 studies from the USA with a follow up of six or more months, neither nicotine patch[@ref42][@ref43][@ref44][@ref45][@ref49] nor nicotine gum[@ref40][@ref41] increased abstinence; however, the five studies of nicotine lozenges showed increased SLT abstinence, with RR (CI) between 0.73 (0.34, 1.55) and 1.53 (1.12, 2.09)[@ref46][@ref47][@ref48][@ref50][@ref51] ([Table I](#T1){ref-type="table"}). In the Bangladeshi Stop Tobacco Project, NRT proved effective among 419 Bangladeshi female resident SLT users of UK with RR (CI) of 4.93 (2.02, 2.00) at four weeks, whereas the opposite was noted for nicotine gum or patch among 239 and 130 Bangladeshi origin participants living in the UK[@ref52][@ref53][@ref54] ([Table I](#T1){ref-type="table"}).

Five non-case-control studies on NRT usage for SLT cessation were found. All were conducted among adults and had a follow up period of six months or more. Only one study was performed in Sweden[@ref55] and the rest in the USA[@ref39][@ref56][@ref57][@ref58]. Three studies tested the efficacy of nicotine gum alone in SLT cessation[@ref55][@ref56][@ref57], while one study[@ref58] employed nicotine lozenge; Mushtaq *et al*[@ref39], utilised nicotine gums, patches and lozenges in their participants. A higher benefit of nicotine lozenge in SLT cessation was also observed by Ebbert *et al*[@ref58], *i.e*. 47 per cent quit rate at six months. The quit rate for NRT in general in SLT cessation ranged from 7 to 47 per cent ([Table II](#T2){ref-type="table"}).

[Non-nicotine therapy]{.ul}: A total of six RCTs, three each for bupropion and varenicline for SLT cessation, were found, and all were conducted among adults. All the three bupropion-related studies[@ref59][@ref60][@ref61] were performed in the USA, with one having a follow up of less than six months[@ref59] and the other two having a follow up period of more than six months[@ref60][@ref61]; however, none of these studies showed a positive effect on tobacco abstinence. The three trials of varenicline, were conducted in Scandinavia[@ref62], USA[@ref63] and India[@ref64] with one having a follow up of less than six months[@ref64] and the other two having a follow up period of more than six months. These studies showed increased tobacco abstinence rates at six months compared to placebo ([Table I](#T1){ref-type="table"}). A single non-case-control pilot study in USA reported a quit rate of 15 per cent among adult participants at the end of 12 wk of treatment with varenicline and 10 per cent at the end of six months of follow up[@ref65].

Discussion {#sec1-4}
==========

Globally, a dearth in the published literature regarding SLT cessation intervention trials has been observed (only for 3% WHO-FCTC ratified Parties, *i.e*. 5/179 Parties - Sweden, Norway, India, United Kingdom and Pakistan, apart from the USA). Further, a deficiency in the tobacco cessation support availability in most low-resource and high SLT burden Parties has been reported in the MPOWER 2017, which is required to be strengthened[@ref66].

Studies assessing the efficacy of SLT cessation interventions, especially behavioural interventions, must be carried out by all countries, especially those having a high burden of SLT consumption, as behavioural interventions have been found to have maximum benefit in SLT cessation as compared to pharmacotherapy[@ref7][@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25][@ref26][@ref27][@ref28][@ref29][@ref30][@ref31][@ref32][@ref33][@ref34][@ref35][@ref36][@ref37][@ref38]. The Cochrane review (2015) on the SLT cessation intervention trials also showed results along similar lines, with behavioural interventions proving most efficacious for SLT cessation[@ref6]. Another Cochrane review (2012) also suggested almost similar efficacy of behavioural interventions in both smoking and SLT cessation[@ref67]. The importance of behavioural intervention in the form of brief advice by healthcare professionals for successful SLT cessation has also been undermined and not much research has been performed. The Global Adult Tobacco Survey (GATS) performed in India, Bangladesh, Kenya, Pakistan, Thailand and Uganda reported a considerable variation while tobacco cessation counselling by health professionals (greater consideration for smokers than SLT users)[@ref68]. Two trials in India have been performed successfully utilizing brief advice for tobacco cessation among both smokers and SLT users *i.e*. an overall quit rate of 67.3 per cent was reported by Kaur *et al*[@ref69], and 2.6 per cent by Sarkar *et al*[@ref70], however, the quit rate for SLT users has not been mentioned separately. There is also a lack of formal training for tobacco cessation among health profession students and school personnel, as seen in the Global Health Professions Student Survey and Global School Personnel Survey, respectively[@ref68]. Hence, the same must be encouraged and expanded up to the grass root level, *i.e*. among health workers working in the villages. However, the likelihood of healthcare professionals giving brief advice will be more if tobacco use is recorded in the medical history; but only 20 per cent of countries follow this[@ref71].

Quitlines and telephone support for SLT cessation have proven efficacious as noted in literature[@ref7][@ref9][@ref10][@ref12][@ref13][@ref14][@ref16][@ref17][@ref19][@ref22][@ref28][@ref34][@ref35][@ref39]. In a Cochrane review[@ref6], the pooled risk ratio of 10 studies conducted in the USA, in which telephone support formed part of the intervention, indicated benefit in SLT cessation. It was also noted that a combination of oral examination and telephone support was more beneficial (RR- 2.07, CI-1.61, 2.66), than oral examination alone[@ref6]. However, according to the MPOWER 2017 data[@ref66], only one-third, *i.e*. 31 per cent, Parties have NQLs, the establishment of which needs to be encouraged. In addition, the phone number of the quitlines could be mentioned on the SLT product packet health warnings. To ensure broader coverage, the primary healthcare system, services for treating tuberculosis and human immunodeficiency virus/acquired immunodeficiency syndrome, dental set-ups and non-communicable diseases programmes could also be involved[@ref72].

mHealth services for SLT cessation can be employed as an easy and cost-effective option, especially in the low-income group countries, for smoking cessation. Very few WHO-FCTC ratified countries have provided this facility (24 Parties)[@ref72]. A national, bilingual mCessation programme (tobacco cessation through mobile text messages) was started in 2016 in India. Evaluation at the end of the first year, of more than 12,000 registered users, demonstrated an average quit rate of about seven per cent among both smokers and SLT users six months after enrolment[@ref66]. Based on the information from 12 studies reported in the Cochrane review, 2016[@ref73] (performed mostly in high-income countries such as USA, Australia, UK, Switzerland, New Zealand), smokers who received the mobile phone-based support were around 1.7 times more likely to quit than those who did not, proving this intervention efficacious, which could also be utilized for SLT cessation.

Most studies had adult participants. SLT prevention and cessation programmes must be facilitated in schools such as Project MYTRI[@ref24], especially among students of the lower strata of the society and with a higher early tobacco usage initiation tendency (smoking and/or SLT or both).

In conclusion, SLT cessation intervention-based research needs encouragement globally, especially in the low-income group countries which are deficient in tobacco cessation support. Behavioural interventions have been proven to be an efficacious and feasible modality for tobacco cessation in all settings (low and high resource). Sensitization and imparting of training regarding the same to health professionals and SLT use prevention and cessation-related school programmes need to be encouraged.
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